Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
18.5M
-
Number of holders
-
110
-
Total 13F shares, excl. options
-
13.2M
-
Shares change
-
-1.79M
-
Total reported value, excl. options
-
$196M
-
Value change
-
-$65.5M
-
Put/Call ratio
-
0.15
-
Number of buys
-
57
-
Number of sells
-
-74
-
Price
-
$14.82
Significant Holders of OptimizeRx Corp - Common Stock (OPRX) as of Q3 2022
162 filings reported holding OPRX - OptimizeRx Corp - Common Stock as of Q3 2022.
OptimizeRx Corp - Common Stock (OPRX) has 110 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13.2M shares
of 18.5M outstanding shares and own 71.46% of the company stock.
Largest 10 shareholders include BlackRock Inc. (2.77M shares), VANGUARD GROUP INC (1.01M shares), BLAIR WILLIAM & CO/IL (750K shares), STATE STREET CORP (680K shares), Handelsbanken Fonder AB (516K shares), AVENIR CORP (421K shares), KENNEDY CAPITAL MANAGEMENT, INC. (407K shares), AWM Investment Company, Inc. (400K shares), G2 Investment Partners Management LLC (383K shares), and First Light Asset Management, LLC (364K shares).
This table shows the top 110 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.